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Abstract
Objective We aimed to assess the opinion of Dutch
cardiologists on coronarymicrovascular disease (CMD)
and its management in clinical practice, and to as-
sess the need for a CMD guideline among Dutch
cardiologists.
Methods We developed an online questionnaire in-
cluding different aspects of CMD which was reviewed
by an expert panel. The questionnaire was distributed
by e-mail among all members of the Dutch Society of
Cardiology.
Results A total of 103 cardiologists (70% male) com-
pleted the questionnaire (response rate: 10%). Me-
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dian age and years of experience as a cardiologist were
49± 15 and 12±12 years, respectively. Overall, 93% of
the cardiologists had considered the CMD diagnosis,
85% had ever made such a diagnosis, 90% had treated
a patient with CMD, and 61% had referred patients to
tertiary care. The median (interquartile range) self-
rated knowledge level was 7.0 (2.0) (scale of 0–10).
84% rated their knowledge as sufficient (>5.5) and 58%
viewed CMD as a disease entity. Overall, 61% and
17%, respectively, agreed that evidence-based diag-
nostic and treatment modalities for CMD do not exist,
while 56% believed that CMD patients have a higher
risk for cardiovascular disease and mortality. Finally,
82% of the responders stated that a CMD guideline
is needed, and 91% wanted to receive the guideline
once developed.
What’s new?
 This is the first study investigating the opinion of
cardiologists in the Netherlands on coronary mi-
crovascular disease (CMD), its management in
clinical practice, and the need for a CMD-spe-
cific guideline.
 The majority of cardiologists had considered the
diagnosis of CMD; however, a much lower pro-
portion viewed CMD as a separate disease entity.
 Although the opinion of male and female cardi-
ologists differed regarding some aspects of CMD,
this did not lead to differences in the manage-
ment of patients with CMD or their interest in
and/or their opinion concerning the need for
a guideline.
 The majority of the responders would welcome
a guideline on the diagnosis and management of
CMD for Dutch cardiologists.
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Discussion Fifty-eight per cent of the responders
recognise CMD as a separate disease entity. Our study
underscores the need for a dedicated CMD guideline
for Dutch cardiology practice. However, the response
rate was low (10%), and it is likely that mainly cardi-
ologists interested in CMD have participated in our
study.
Keywords Coronary microvascular diseas · Survey
questionnaire · Opinion poll · Practice guidelines
Background
Coronary microvascular disease (CMD) is defined as
the presence of signs and symptoms of ischaemia, in
the absence of epicardial obstruction, with evidence
of coronary microvascular dysfunction. It is a com-
mon condition in clinical practice, which affects both
men and women [1–3]. Although CMDwas previously
thought to have a benign prognosis, recent studies
have shown increased mortality among patients with
CMD compared to patients without CMD. Further-
more, symptoms are often sustained and severe, giv-
ing rise to a diminished quality of life [4, 5]. Despite
the reports regarding the large prevalence of CMD in
clinical practice [3], the disease is often underdiag-
nosed, since the focus in ischaemic heart disease is
still on coronary artery stenosis. As a consequence,
CMD patients often undergo repeated (invasive) di-
agnostic tests and hospital admissions with associ-
ated high health care costs [6]. The European Society
for Cardiology and the American Heart Association/
American College of Cardiology acknowledge CMD as
a separate disease entity and included recommenda-
tions for CMD in their latest editions of guidelines on
stable coronary artery disease [7, 8]. However, the
existing guidelines offer limited guidance on how to
diagnose and treat these patients in clinical practice
and mainly focus on symptom management.
So far, data concerning the Dutch cardiologists’
view with regard to CMD is lacking. Moreover, it is
not clear whether developing a guideline on CMD
would be welcomed by Dutch cardiologists. There-
fore, our aim was to assess the opinion of Dutch
cardiologists on CMD, its management in clinical
practice in the Netherlands, as well as the need for
a CMD guideline.
Methods
We conducted a cross-sectional self-administered
questionnaire survey among cardiologists in the
Netherlands. A formal online questionnaire was de-
veloped using expert consensus. The questionnaire
contained 26 items, consisting of 5 on CMD in clinical
practice, 6 concerning the cardiologists’ view on and
their knowledge of CMD, 5 regarding the need for
a guideline on CMD, and 10 demographic items to
characterise the study population (see the Electronic
Supplementary Material for the questionnaire). The
questionnaire was reviewed by an expert panel of
the Gender Working Group of the Dutch Society of
Cardiology (NVVC) and was validated in a represen-
tative group of individuals of the target population,
among cardiologists across the Netherlands working
in academic and/or non-academic hospitals. Next,
the questionnaire was distributed to all members of
the NVVC by e-mail together with the weekly newslet-
ter. The questionnaire could be completed between
6 December 2018 and 15 January 2019. Participation
was voluntary and anonymous.
Associations between survey responses and charac-
teristics of the participants were evaluated by univari-
ate analyses. χ2 tests were performed to compare di-
chotomous variables. The Mann-Whitney U test was
performed for the comparison of non-normally dis-
tributed continuous variables. We further performed
stratified analysis based on years of experience (di-
chotomised at the median) and also whether or not
the cardiologists were currently involved in research.
To test for non-response bias, we performed a sensi-
tivity analysis in which we compared the two groups
of early and late responders. Early responders were
defined as those who had completed the question-
naire within 6 days after receiving the e-mail. A two-
sided p-value of <0.05 was regarded as statistically sig-
nificant. Statistical analysis was performed with IBM
SPSS Statistics software version 24.
Results
Data are presented as frequencies and percentages
for nominal variables, or medians and interquartile
ranges for continuous variables.
Demographics
The questionnaire was sent to 1905 members of the
NVVC, of whom 1,044 were cardiologists. Of the 124
responders, 103 were cardiologists and 17 were cardi-
ologists in training, cardiology residents not in train-
ing, or physician assistants. As this last group repre-
sented a minority, they were excluded. Therefore, the
response rate was 10% among the cardiologists.
Among the responders, median (interquartile range)
age and years of experience as a cardiologist were
49± 15 and 12±12 years, respectively, and 70% were
male. The majority of the responders had completed
training in a sub-speciality (78%), including interven-
tional cardiology (26%), non-invasive imaging (25%)
or any other sub-speciality (23%), while 4% of the
responders declared themselves to be specialised in
‘female cardiology’. A large proportion (65%) of the
responders were currently involved in research, and
59% had a PhD degree. More than two-thirds (71%)
of the responders were working in a non-academic
hospital, 22% were working in an academic hospital,
while 2% were working in both academic and non-
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Table 1 Demographics
of responding cardiologists
(n= 103)
Cardiologists Response rate
Age, years 49 (15) 99%
Sex, male 70% 100%a
Experience as a cardiologist, years 12 (12) 93%
Practice setting 100%a
– Academic hospital 22%
– Non-academic hospital 71%
– Both in academic and non-academic hospital 2%
– Private clinic 5%
Sub-specialty 78% 100%
– Interventional cardiology 26%
– Non-invasive imaging 25%
– Women’s heart health 4%
– All others 23%
PhD degree 59% 100%a
Currently involved in research 65% 100%a
Average number of patients per month 200 (170) 95%
Average number of new patients with angina per month 30 (38) 88%
aResponse was obligatory
Data represent frequencies and proportions for categorical data and median (interquartile range) for continuous variables
academic hospitals, and 5% in a private clinic. The
median (interquartile range) for the number of new
patients per month was 200 (170), and the number of
new patients with angina per month amounted to 30
(38) (Tab. 1).
Opinion of cardiologists on diagnosis, prognosis
and CMD as a disease entity
The median (interquartile range) self-rated level of
knowledge among cardiologists was 7.0 (2.0) on a scale
Table 2 Cardiologists’
view regarding coronary mi-
crovascular disease (CMD)
as a disease entity and its
diagnosis and prognosis
(n= 103)
Cardiologists
Self-rated knowledge 7.0 (2.0)a
CMD is a disease entity
– Agree 58%
– Disagree 14%
– Do not know 28%
Evidence-based diagnostic modalities to diagnose CMD do not exist
– Agree 61%
– Disagree 31%
– Do not know 8%
Treatment options for patients with CMD do not exist
– Agree 17%
– Disagree 70%
– Do not know 15%
Patients with CMD have a higher risk for cardiovascular disease and mortality
– Agree 56%
– Disagree 18%
– Do not know 26%
aOn a scale of 0–10: 1 indicates very low, 10 indicates high
Data represent proportions for categorical variables and median (interquartile range) for continuous variables
of 0 to 10. Of the responders, 84% rated their knowl-
edge as sufficient (>5.5). Overall, 58% of the car-
diologists viewed CMD as a separate disease entity.
Although 61% agreed that evidence-based diagnostic
modalities do not exist for the diagnosis of CMD, only
17% of responders agreed that treatment options do
not exist. Moreover, 56% of cardiologists agreed that
patients with CMD have a higher risk for cardiovascu-
lar disease and mortality (Tab. 2).
The self-rated knowledge level did not differ signif-
icantly between male and female cardiologists. How-
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ever, the opinion of male and female cardiologists dif-
fered considerably, as 51% of male cardiologists versus
74% of female cardiologists viewed CMD as a separate
disease entity (p= 0.05). Also, 21% of male versus 7%
of female cardiologists stated that treatment options
do not exist (p= 0.03), and 44% versus 84% supported
the statement that CMD leads to a higher cardiovas-
cular morbidity and mortality (p=0.001).
Responses to various questions differed signifi-
cantly among cardiologists who viewed CMD as a dis-
ease entity compared to cardiologists who did not:
52% versus 79% stated that evidence-based diagnos-
tic modalities do not exist (p<0.0001), 8% versus 50%
believed treatment options do not exist (p<0.0001),
and 77% versus 29% stated that CMD leads to a higher
cardiovascular morbidity and mortality (p<0.0001).
Clinical practice
Among the responders, the majority (93%) had con-
sidered the diagnosis of CMD in their practice (Fig. 1).
Moreover, 85% and 90% of the cardiologists, respec-
tively, had ever diagnosed or treated a patient with
CMD in their clinic. Cardiologists who viewed CMD
as a separate disease entity had more often considered
the diagnosis, had ever diagnosed or treated CMD
compared to cardiologists who did not: 98% versus
57% (p< 0.0001), 95% versus 43% (p<0.0001) and 97%
versus 57% (p<0.001), respectively. Responses did not
differ between cardiologists working in an academic
versus a non-academic hospital.
Overall, 61% of the responders stated that they re-
fer patients to third-line care or specialised clinics.
One third of the responders referred patients based
on both the request of patients and their own deci-
sion. Only 7% made a referral based on only their
own decision, and 20% referred only at the request of
the patients.
Among the responders that did not consider the
diagnosis of CMD in clinical practice, a considerable
proportion (43%) still stated that they had ever di-
agnosed or treated a patient with CMD in their own
clinic or that they had referred patients.
Fig. 1 Experience of cardiologists regarding coronary microvascular disease (CMD)
Although more female than male cardiologists had
ever diagnosed a patient with CMD (97% vs 80%,
p= 0.02), responses regarding consideration of the
diagnosis and patient referral for CMD did not signif-
icantly differ between the two genders.
Treatment of CMD
The most frequent used treatment options were cal-
cium channel blockers, nitrates, statins, and lifestyle
intervention, prescribed by 93%, 91%, 79%, and 92%
of the responders, respectively (Fig. 2).
Sex differences in CMD
A large proportion of the responders (86%) indicated
that sex differences exist for CMD: 86%, 85%, and
61% of responders stated that sex differences exist for
prevalence, symptoms and risk factors in patients with
CMD, respectively. However, a much lower proportion
believed that sex differences are applicable to diagno-
sis, treatment, and prognosis (35%, 39%, and 33%,
respectively). (Fig. 3).
Guideline on CMD
The majority of responding cardiologists (82%) indi-
cated that a guideline for CMD is needed, and an
even larger proportion (91%) wanted to receive the
guideline once developed. Compared to cardiologists
practicing in academic hospitals, a larger proportion
of cardiologists practicing in non-academic hospitals
stated that there is a need for a CMD guideline (64%
vs 87%, respectively; p= 0.01). In addition, 93% of
cardiologists who viewed CMD as a separate disease
entity, but only 50% of those who did not, responded
that a CMD guideline was needed (p< 0.001). No dif-
ferences were observed between male and female re-
sponders.
When responders were asked which topics should
be included in the guideline, between 82% and 85%
specified prevalence, prognosis, risk factors, and sex
Questionnaire survey on cardiologists’ view andmanagement of coronary microvascular disease in clinical. . . 259
Original Article
Fig. 2 Treatment options
used by Dutch cardiologists
for coronary microvascular
disease (CMD)
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Fig. 3 Cardiologists’ view regarding sex differences in coro-
nary microvascular disease (CMD)
differences, while 95% indicated diagnosis and treat-
ment.
Discussion
We investigated the view of Dutch cardiologists on
CMD, its management in clinical practice, and the
need for a specific guideline for CMD. The results of
the questionnaire underscore that the majority of the
responding Dutch cardiologists would welcome a spe-
cific guideline for CMD.
Interpretation of findings
The results from this survey should be interpreted in
the context of several potential limitations. Firstly, the
response rate was limited (10%). However, using the
available demographic information of the total group
of cardiologists that are members of the NVVC, the
demographics of responders in the current study were
comparable to those of the total group (70% vs 74%
were male, 59% vs 56% had a PhD degree, and me-
dian age was 49 vs 45 years, respectively). Therefore,
although the response rate was limited, our popula-
tion of interest may still be representative of the total
group of cardiologists. Secondly, although the target
population was well represented, non-response might
be related to the topic under study, and the respon-
ders may reflect those with a greater degree of inter-
est and knowledge pertaining to CMD, thus leading
to overestimation of the results. This might explain
the rather high percentages for various questions ob-
served in this study. However, a sensitivity analysis
comparing early and late responders, assuming late
responders behave similar to non-responders, yielded
similar results. Another explanation might be that re-
cent media attention in the Netherlands has been ef-
fective in raising awareness for CMD among cardiolo-
gists. Nevertheless, as the survey was dependent upon
voluntary participation, and thus vulnerable for non-
response bias, the true percentages remain unknown.
Consequently, the generalisability of our results might
be constrained by the characteristics of our sample
population. Thirdly, as in most surveys, the present
study relied on self-report and did not validate self-
reports against objective measures.
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Strengths
We developed a questionnaire including a broad range
of topics and covering different aspects of CMD which
was reviewed by an expert panel. Moreover, the ques-
tionnaire was distributed by the NVVC. As almost all
cardiologists in the Netherlands are members of the
NVVC, this ensuredwidespread distribution across the
Netherlands.
Cardiologists’ view on CMD
Although the majority of the responders considered
the diagnosis of CMD, a much lower proportion
viewed CMD as a separate disease entity. In line
with this, the latter group responded less positively
to the question regarding the need for a specific
CMD guideline. Thus, despite accumulating scientific
evidence regarding CMD being a distinctive type of
ischaemic heart disease, 58% of the responding Dutch
cardiologists do not agree on this.
Diagnosis and management of CMD in clinical
practice
An important and encouraging observation from this
survey is that the majority of physicians considered
the diagnosis of CMD in their practice. Also, a large
proportion of cardiologists preferred to manage pa-
tients with CMD in their own clinic by themselves.
If our survey reflects the real clinical practice in the
Netherlands, our results indicate that the manage-
ment of CMD patients is not restricted to specialised
centres. This emphasises the need for a CMD guide-
line for the clinical practice of cardiologists. Our study
also showed that although the opinion of male and
female cardiologists differed in some aspects, this did
not lead to differences in the management of CMD in
clinical practice or agreement on the need for a guide-
line.
Implications of findings
Several aspects of our results highlighted the need
for a CMD guideline. Firstly, a large percentage of
cardiologists practicing in non-academic hospitals
preferred to manage patients suspected of having
CMD by themselves, rather than referring them to
specialised centres. Secondly, our study highlighted
differences in the management of CMD in clinical
practice. Thirdly, although the self-rated knowledge
was more than sufficient among the majority of the
responders and despite the differences in opinion
regarding CMD as a disease entity, the majority of
responders agreed on the need for a guideline on
CMD.
Conclusion
Overall, 58% of the responders recognise CMD as
a separate disease entity. The majority of responding
Dutch cardiologists would welcome a guideline on
the diagnosis and management of CMD in clinical
practice.
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